Ibogaine Research Hub
Exploring the frontier of pharmacological research and clinical trials, our hub provides a centralized database for the most significant developments in ibogaine therapy.
Research Hubs
Addiction Treatment
Provides peer-reviewed research on molecular pathways, focusing on how pharmacological interventions reset brain reward systems to interrupt chemical dependency and sustained drug-seeking behaviors effectively.
Neurological & Cognitive
Brain Rehabilitation Research Center (BRRC)
Leads research into neuroplasticity-driven recovery, detailing how clinical protocols stimulate neural repair and cognitive rehabilitation for patients suffering from long-term trauma and substance-induced impairment.
The Iboga Wellness Institute (Safety Standards)Â
Establishes rigorous clinical safety standards, specializing in cardiac screening and EKG monitoring protocols to transform botanical treatments into standardized, medically-controlled, and high-security procedures.
Safety & Risk
Policy & Economics
RAND Drug Policy Research Center
Delivers sophisticated fiscal analysis on drug policy, calculating the socio-economic ROI of effective treatments by measuring reductions in public health expenditures and criminal recidivism.
This page provides a comprehensive database for monitoring the intellectual property landscape of ibogaine and its related compounds. It tracks the status, assignees, and specific claims of various patents to help stakeholders navigate the evolving legal and commercial environment.
Over the past decades we have develop The 66-Day Neuro-Restorative & Integrative Protocol (NRIP)" A comprehensive, multi-phase clinical framework designed to facilitate long-term neuroplasticity and sustained behavioral remission.
Economic & Outcome Metrics
Conceptualizing the quantitative impact of Ibogaine necessitates a multi-dimensional approach to metrics. Our analysis focuses on patient outcome indices, long-term retention rates within recovery ecosystems, and the broader macro-economic cost impact on public health infrastructure. By evaluating these key performance indicators, we can project the systemic benefits of integrating Ibogaine into standardized therapeutic protocols. These models serve as an educational framework for understanding evidence-based healthcare reform.
Institutional Synergy
We bridge the gap between academic research and clinical application by partnering with respected universities and research institutions. Our collaborative framework supports rigorous clinical trials and deep economic modeling to substantiate the transformative potential of ibogaine in modern healthcare systems.
Through strategic alliances with global non-profits and specialized clinics, we foster an ecosystem rooted in ethical sourcing and patient-centric outcomes. Together, we identify significant funding opportunities to scale infrastructure and establish standard-setting neurological evaluation metrics.